Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2009
03/12/2009WO2009032179A1 Phosphadiazine hcv polymerase inhibitors iii and vi
03/12/2009WO2009032177A1 Phosphadiazine hcv polymerase inhibitors i and ii
03/12/2009WO2009032176A1 Phosphadiazine hcv polymerase inhibitors v
03/12/2009WO2009032158A2 Delayed self-gelling alginate systems and uses thereof
03/12/2009WO2009032125A1 2,3-substituted azaindole derivatives for treating viral infections
03/12/2009WO2009032124A1 Substituted indole derivatives and methods of use thereof
03/12/2009WO2009032123A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections
03/12/2009WO2009032116A1 2, 3-substituted indole derivatives for treating viral infections
03/12/2009WO2009032057A2 Method for the selective therapy of disease
03/12/2009WO2009032034A2 Stabilized picoplatin dosage form
03/12/2009WO2009031999A1 Fr901464 and analogs with antitumor activity and method for their preparation
03/12/2009WO2009031943A1 Method for monitoring diabetes insulin therapy
03/12/2009WO2009031922A1 Tablet for prophylaxis and treatment of dental and periodontium diseases
03/12/2009WO2009031919A1 Alcoholism recurrence preventing agent and method for the use thereof
03/12/2009WO2009031879A1 Pharmaceutical composition combining betamethasone (steroidal anti-inflammatory agent) and methocarbamol (muscle relaxant) and use thereof in the treatment of musculoskeletal diseases
03/12/2009WO2009031878A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency
03/12/2009WO2009031877A1 Pharmaceutical composition combining acemetacin, methocarbamol and diacerein, which can be used in the treatment of rheumatoid arthritis and related diseases
03/12/2009WO2009031876A1 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer
03/12/2009WO2009031842A1 Use of trim72 as a target for muscle and heart enhancer
03/12/2009WO2009031819A2 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient
03/12/2009WO2009031709A1 Coumarin compound and use thereof
03/12/2009WO2009031708A1 Coumarin compound and use thereof
03/12/2009WO2009031706A1 Coumarin compound and use thereof
03/12/2009WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN
03/12/2009WO2009031694A1 Powder composition
03/12/2009WO2009031682A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE
03/12/2009WO2009031671A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method
03/12/2009WO2009031644A1 Antifungal pharmaceutical composition
03/12/2009WO2009031643A1 Antifungal composition
03/12/2009WO2009031642A1 Pharmaceutical composition
03/12/2009WO2009031627A1 Para-terphenyl compound or pharmacologically acceptable salt thereof, method for production of the same, and use of the same
03/12/2009WO2009031577A1 Injection, injection solution and injection kit preparation
03/12/2009WO2009031576A1 Process for producing valacyclovir hydrochloride crystal
03/12/2009WO2009031575A1 Therapeutic or prophylactic agent for posterior ocular disease comprising lithium salt as active ingredient
03/12/2009WO2009031318A1 Preparation for external application comprising analgesic/anti-inflammatory agent
03/12/2009WO2009031195A1 Composition containing flavanone compound monomer
03/12/2009WO2009031051A2 Stabilized anthocyanin compositions
03/12/2009WO2009031029A1 Treatment of cns and pain disorders
03/12/2009WO2009031011A2 Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
03/12/2009WO2009031006A2 Antiviral topical formulations in the form of a bio-adhesive gel
03/12/2009WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030968A1 Mao a inhibitors with a diphenyl ether-substructure.
03/12/2009WO2009030962A1 Bicyclic aryl and heteroaryl receptor modulators
03/12/2009WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
03/12/2009WO2009030929A1 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
03/12/2009WO2009030890A1 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma
03/12/2009WO2009030871A1 Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
03/12/2009WO2009030862A2 Use of travoprost for treating hair loss
03/12/2009WO2009030773A1 Pharmaceutical composition effective against biofilms
03/12/2009WO2009030752A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them
03/12/2009WO2009030750A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009WO2009030747A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/12/2009WO2009030746A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/12/2009WO2009030725A2 Azaindoles as inhibitors of soluble adenylate cyclase
03/12/2009WO2009030716A1 Piperazine derivative having affinity for the histamine h3 receptor
03/12/2009WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009WO2009030440A2 Sidna against hepatitis c virus (hcv)
03/12/2009WO2009030410A1 Improvements in or relating to compositions for the treatment or prophylaxis of viral infections
03/12/2009WO2009030333A1 Thiadiazinone derivatives
03/12/2009WO2009030316A1 1,3-dihydroisoindole derivatives
03/12/2009WO2009030270A1 Dihydroindole derivatives useful in parkinson's disease
03/12/2009WO2009030257A1 Methods and compounds for treating diseases caused by reactive oxygen species
03/12/2009WO2009030153A1 The roles of mirnas in the diagnosis and treatment of systemic lupus erythematosus
03/12/2009WO2009030116A1 The use of alkaloids in preparation of medicament for treating cough
03/12/2009WO2009030107A1 Benzenesulfonamido methylene substituted mercapto pyrrolidine carbapenem derivatives
03/12/2009WO2009030106A1 7-(4-oximino-3-amino-1-piperidyl)quinolinecarboxylic acid derivatives and their preparation methods
03/12/2009WO2009030073A1 A dTDP-β-D-FUCOFURANOSE, ITS PREPARATION METHOD AND USE
03/12/2009WO2009029998A1 Retrometabolic compounds
03/12/2009WO2009018478A3 Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
03/12/2009WO2009018106A3 Stereoselective process for preparing purine dioxolane nucleoside derivatives
03/12/2009WO2009013435A3 Preservative-free prostaglandin-based ophthalmic solution
03/12/2009WO2009012551A4 Resveratrol complex and process for the preperation
03/12/2009WO2009011617A3 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS
03/12/2009WO2009010974A8 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
03/12/2009WO2009010921A3 Method of regulating hair growth
03/12/2009WO2009010871A3 Pyrazole derivatives as antagonists of adenosine a3 receptor
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2009010139A3 Quinazolinamide derivatives
03/12/2009WO2009009480A3 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid
03/12/2009WO2009009449A3 Phospholipase a2 inhibitors and their use in treating neurological injury and disease
03/12/2009WO2009008901A3 Peptide and small molecule agonises of epa and their uses in diseases
03/12/2009WO2009008632A3 Gastroretentive system containing solubilized drug for maximizing its therapeutic effect for gastritis
03/12/2009WO2009007680A3 Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
03/12/2009WO2009007679A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
03/12/2009WO2009007675A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
03/12/2009WO2009007415A3 Novel compounds
03/12/2009WO2009007334A3 Transdermal therapeutic systems which contain the substance anastrozole
03/12/2009WO2009006590A3 Docetaxel process and polymorphs
03/12/2009WO2009004082A3 Anticonvulsive pharmaceutical compositions
03/12/2009WO2009004058A3 Novel prolactin compounds
03/12/2009WO2009002229A3 New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
03/12/2009WO2009002228A3 New thrombin function compounds and pharmaceutical compositions based on them
03/12/2009WO2009001043A3 Duloxetine formulation
03/12/2009WO2009000853A3 Combination formulations comprising darunavir and etravirine
03/12/2009WO2008157751A3 Substituted imidazoheterocycles
03/12/2009WO2008156671A3 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
03/12/2009WO2008155668A3 Heteroarylamide pyrimidone compounds
03/12/2009WO2008151746A3 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE
03/12/2009WO2008149244A3 Compositions and methods comprising analogues of radicicol a
1 ... 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 ... 7860